- $278.56bn
- $1.28tn
- $125.10bn
- 44
- 55
- 97
- 73
REG - Goldman Sachs (EPT) Avadel Pharma plc - Form 38.5b - Avadel Pharmaceuticals plc
AnnouncementREG - Goldman Sachs & Co. Avadel Pharma plc - Form 38.5b Avadel Pharmaceuticals plc
AnnouncementREG - GS Alpha Enhncd EA $ - Net Asset Value(s)
AnnouncementREG - GS Alpha Enhncd EM $ - Net Asset Value(s)
AnnouncementREG - GS Alpha Enhcd Jpn £ - Net Asset Value(s)
AnnouncementREG - GS Activebeta EME $ - Net Asset Value(s)
AnnouncementREG - GS Green Bond ETF E - Net Asset Value(s)
AnnouncementREG - GS Green Bond ETF $ - Net Asset Value(s)
AnnouncementREG - Goldman Sachs ETF - Net Asset Value(s)
AnnouncementREG - GS Alpha Enhncd EA£ - Net Asset Value(s)
AnnouncementREG - Goldman Sachs (EPT) Avadel Pharma plc - Irish Takeover Panel 38.5b Avadel Pharmaceuticals
AnnouncementREG - Goldman Sachs & Co. Avadel Pharma plc - Irish Takeover Panel 38.5b Avadel Pharmaceuticals
AnnouncementREG - J.P. Morgan SE - Stabilisation Notice
AnnouncementREG - Permanent TSB Group Goldman Sachs GrpInc - Holding(s) in Company
AnnouncementREG - Goldman Sachs (EPT) Avadel Pharma plc - Irish Takeover Panel -38.5a Avadel Pharmaceuticals
AnnouncementREG - Goldman Sachs & Co. Avadel Pharma plc - Irish Takeover Panel 38.5b Avadel Pharmaceuticals
AnnouncementREG - Goldman Sachs (EPT) Avadel Pharma plc - Irish Takeover Panel 38.5b Avadel Pharmaceuticals
AnnouncementREG - Goldman Sachs ETF - Net Asset Value(s)
AnnouncementREG - GS Alpha Enhncd EA£ - Net Asset Value(s)
Announcement